Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico

[1] Younossi Z(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 15 11-20

[2] Anstee QM(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-357

[3] Marietti M(2010)Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 1820-1832

[4] Hardy T(2011)Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis Int J Cancer 128 2436-2443

[5] Henry L(2019)Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Clin Gastroenterol Hepatol 17 748-755

[6] Eslam M(2011)Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 124-131

[7] George J(2004)Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 1387-1395

[8] Bugianesi E(2018)Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis Clinical Gastroenterology and Hepatology 16 198-210. e192

[9] Chalasani N(2005)Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease Hepatology 41 372-379

[10] Younossi Z(2016)Nonalcoholic Fatty Liver Disease in Latinos Clinical Gastroenterology and Hepatology 14 5-12

[1] Younossi Z(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 15 11-20

[2] Anstee QM(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-357

[3] Marietti M(2010)Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 1820-1832

[4] Hardy T(2011)Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis Int J Cancer 128 2436-2443

[5] Henry L(2019)Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Clin Gastroenterol Hepatol 17 748-755

[6] Eslam M(2011)Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 124-131

[7] George J(2004)Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 1387-1395

[8] Bugianesi E(2018)Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis Clinical Gastroenterology and Hepatology 16 198-210. e192

[9] Chalasani N(2005)Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease Hepatology 41 372-379

[10] Younossi Z(2016)Nonalcoholic Fatty Liver Disease in Latinos Clinical Gastroenterology and Hepatology 14 5-12